World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
91
Citations
28064
World Ranking
2334
National Ranking
1247

Medicine

D-Index
91
Citations
28020
World Ranking
11832
National Ranking
6067

Raj K. Puri publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Raj K. Puri sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 326 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Raj K. Puri D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Raj K. Puri sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 91 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Raj K. Puri is affiliated with the US Food and Drug Administration in the United States. Their research spans multiple fields of study, mainly focusing on Medicine, Biochemistry, Genetics and Molecular Biology, and Engineering. Within these fields, Puri's work is notably concentrated in several subfields including Oncology, Biomedical Engineering, Immunology, Molecular Biology, and Genetics.

The primary topics addressed in Puri's research include CAR-T cell therapy research, Toxin Mechanisms and Immunotoxins, Nanowire Synthesis and Applications, Viral Infectious Diseases and Gene Expression in Insects, Virus-based gene therapy research, Nanofabrication and Lithography Techniques, and Transgenic Plants and Applications.

Recent published papers reflect this breadth of research:

  • Identification and characterisation of novel CAR-T cells to target IL13Rα2 positive human glioma in vitro and in vivo, 2024, Clinical and Translational Medicine
  • Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with 89Zirconium oxine for PET imaging, 2023, Journal of Translational Medicine
  • Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy, 2022, Frontiers in Immunology
  • Clinical Development of Gene Therapies: The First Three Decades and Counting, 2020, Molecular Therapy - Methods & Clinical Development
  • A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma, 2020, Cancers

Puri's frequent coauthors include Bharat Joshi with whom they have collaborated on nine occasions, Pamela Leland and Steven R. Bauer with five joint publications each, Dhiraj Kumar with three, and SuJin Hwang with two.

The scientist's work is regularly published in a number of scholarly venues. Among these, the most frequent publication venues are the Journal of Translational Medicine, Frontiers in Immunology, Molecular Therapy - Methods & Clinical Development, Cancers, and Clinical and Translational Medicine.

Best Publications

  • The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

    Leming Shi;Laura H. Reid;Wendell D. Jones;Richard Shippy

  • IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis.

    Stefan Fichtner-Feigl;Warren Strober;Koji Kawakami;Raj K Puri

  • The Microarray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

    Leming Shi;Gregory Campbell;Wendell D. Jones;Fabien Campagne

  • Gene expression in human embryonic stem cell lines: unique molecular signature

    Bhaskar Bhattacharya;Takumi Miura;Ralph Brandenberger;Josef Mejido

  • Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

    Sandeep Kunwar;Susan Chang;Manfred Westphal;Michael Vogelbaum

  • MSC-based product characterization for clinical trials: an FDA perspective

    Michael Mendicino;Michael Mendicino;Alexander M. Bailey;Keith Wonnacott;Raj K. Puri

  • Receptor for Interleukin 13: INTERACTION WITH INTERLEUKIN 4 BY A MECHANISM THAT DOES NOT INVOLVE THE COMMON γ CHAIN SHARED BY RECEPTORS FOR INTERLEUKINS 2, 4, 7, 9, AND 15

    Nicholas I. Obiri;Waldemar Debinski;Warren J. Leonard;Raj K. Puri

  • The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies

    Leming Shi;Wendell D. Jones;Roderick V. Jensen;Stephen C. Harris

  • The External RNA Controls Consortium: a progress report.

    Shawn C Baker;Steven R Bauer;Richard P Beyer;James D Brenton

  • cDNA Cloning and Characterization of the Human Interleukin 13 Receptor α Chain

    M. Javad Aman;Nahid Tayebi;Nicholas I. Obiri;Raj K. Puri

  • Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

    Sandeep Kunwar;Michael D. Prados;Susan M. Chang;Mitchel S. Berger

  • A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4

    Waldemar Debinski;Nicholas I. Obiri;Ira Pastan;Raj K. Puri

  • Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.

    W Debinski;N I Obiri;S K Powers;I Pastan

  • Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.

    Robert W. Rand;Robert J. Kreitman;Nicholas Patronas;Frederick Varricchio

  • The interleukin-13 receptor α2 chain: an essential component for binding and internalization but not for interleukin-13–induced signal transduction through the STAT6 pathway

    Koji Kawakami;Jun Taguchi;Takashi Murata;Raj K. Puri

  • Medical applications of microarray technologies: a regulatory science perspective

    Emanuel F. Petricoin;Joseph L. Hackett;Lawrence J. Lesko;Raj K. Puri

  • Poor drug distribution as a possible explanation for the results of the PRECISE trial.

    John H. Sampson;Gary Archer;Christoph Pedain;Eva Wembacher-Schröder

  • Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential.

    Leming Shi;Weida Tong;Hong Fang;Uwe Scherf

  • Polypeptide components of two 8 S forms of chicken oviduct progesterone receptor

    J J Dougherty;R K Puri;D O Toft

  • Cell and gene therapies: moving from research to clinic

    David F Stroncek;Raj K Puri

Frequent Co-Authors

Ira Pastan
Ira Pastan Center for Cancer Research
Robert J. Kreitman
Robert J. Kreitman National Cancer Institute
Cory M. Hogaboam
Cory M. Hogaboam Cedars-Sinai Medical Center
Hong Fang
Hong Fang National Center for Toxicological Research
Mahendra S. Rao
Mahendra S. Rao National Institutes of Health
Leming Shi
Leming Shi Fudan University
Claudia Jakubzick
Claudia Jakubzick Dartmouth College
Roger Perkins
Roger Perkins United States Food and Drug Administration
John H. Sampson
John H. Sampson Duke University
Susan M. Chang
Susan M. Chang University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Raj K. Puri

Trending Scientists

Recently Published Articles